CRVO

CervoMed Inc.

Insider Trades

NameValueActionPriceCurrent Price
Elder William RobertCFO, GC & Secretary
$21k2.5k shares
BuyNov 18, 2025
$8.32
--
Winton MatthewChief Commercial And Business
$12k1.5k shares
BuyNov 18, 2025
$7.95
--
Alam John JDirector, 10 Percent Owner, Officer: CEO & President
$91k10.8k shares
BuyNov 17, 2025
$8.46
--
Alam John JDirector, 10 Percent Owner, Officer: CEO & President
$91k10.8k shares
BuyNov 17, 2025
$8.46
--
Gregoire SylvieDirector, 10 Percent Owner:
$91k10.8k shares
BuyNov 17, 2025
$8.46
--
Gregoire SylvieDirector, 10 Percent Owner:
$91k10.8k shares
BuyNov 17, 2025
$8.46
--

News

globenewswire.comCervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rulesglobenewswire.comJun 18globenewswire.comCervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042globenewswire.comJun 18globenewswire.comCervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summitglobenewswire.comJun 12globenewswire.comCervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodiesglobenewswire.comJun 10globenewswire.comCervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updatesglobenewswire.comMay 18
CRVO smart money exposure | 交易笔记